glp-1 shortage canada news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our National Hispanic Medical Association |

Graphical abstract Fig

Moreover, all included studies were observational in nature, making them susceptible to residual confounding and selection bias

An insurer covering a 45-year-old, for example, might shoulder the cost of weight lost medications for a decade or so, but sooner or later, those employees will retire, and their health care costs shift to Medicare

A 2026 study in mice also ties GLP1 receptor agonist effectiveness for weight loss to the bodys ability to use fatty acids for energy

The practical effect: you feel full faster, stay full longer, and experience less food noise (constant thoughts about food, cravings, snacking urges)